Abstract Importance Metabolic dysfunction-associated steatotic liver disease (MASLD) is an increasing cause of cirrhosis
Tesamorelin has the rigorous Phase III data, the FDA approval for adult use, the documented 15 percent visceral fat reduction, and the favorable metabolic profile that comes with that fat loss
FDA Advisory Committee Recommends Adding BPC-157 to Compounding List A closely watched FDA advisory committee has voted to recommend adding BPC-157 to the list of bulk drug substances that may be used by traditional compounding pharmacies, marking a potentially significant development for providers who have followed growing interest in peptide therapies
Ben: Other things to know about these GLP-1 drugs today, for Diabetes, I try to basically figure out from asking around, what are people actually paying for this
et al: Nature Med
15 Conclusion Probiotics have emerged as versatile modulators of human health, with evidence supporting their role in GI disorders, metabolic diseases, infections, inflammatory conditions, cancer, and neurological health
